DSpace Repositorium (Manakin basiert)

Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern

Zur Kurzanzeige

dc.contributor.author Matas-García, Ana
dc.contributor.author Milisenda, José C.
dc.contributor.author Selva O'Callaghan, Albert
dc.contributor.author Prieto-González, Sergio
dc.contributor.author Padrosa, Joan
dc.contributor.author Cabrera, Carlos
dc.contributor.author Reguart, Noemi
dc.contributor.author Castrejón, Natalia
dc.contributor.author Solé, Manel
dc.contributor.author Ros, Javier
dc.contributor.author Trallero-Araguas, Ernesto
dc.contributor.author Antoniol, María Noelia
dc.contributor.author Vila-Pijoan, Gemma
dc.contributor.author Grau, Josep María
dc.date.accessioned 2020-12-30T11:40:28Z
dc.date.available 2020-12-30T11:40:28Z
dc.date.issued 2020-02
dc.identifier.citation Matas-García, A., Milisenda, J.C., Selva-O’Callaghan, A., Prieto-González, S., Padrosa, J., Cabrera, C., Reguart, N., Castrejón, N., Solé, M., Ros, J., Trallero-Araguas, E., Antoniol, M.N., Vila-Pijoan, G., Grau, J.M., 2020. Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern. Autoimmun Rev 19, 102455. https://doi.org/10.1016/j.autrev.2019.102455 en_US
dc.identifier.uri https://repositorio.fleni.org.ar/handle/123456789/290
dc.identifier.uri https://doi.org/10.1016/j.autrev.2019.102455
dc.description.abstract Background and objective: Drug-induced myopathy is among the most common causes of muscle disease. An association has recently been described between programmed death-1 (PD-1)/PD-1 ligand (PD-L1) inhibitors and immune-related adverse events (irAE) affecting the muscle. Here, we report the clinical and pathological findings of nine unrelated patients with PD-1 and PD-L1 inhibitors-associated myopathy. Methods: We retrospectively analyzed 317 muscle biopsies performed for diagnostic purposes from January 2017 to June 2019. Patients were attended in two tertiary centers and muscle biopsies were performed and analyzed by two myology experts. Muscle biopsies were frozen in cooled isopenthane, cryostat sectioned and stained. Immunohistochemistry studies were also performed as a routine procedure in our lab. Results: We identified 9 patients receiving anti-PD-1 or PD-L1 inhibitors consulting for either muscle weakness, asthenia, myasthenic-like syndrome or other muscle related-symptoms, along with biopsy-proven inflammatory myopathy. One had concomitant myocarditis. In most of the cases muscle biopsy showed a marked phenomenon of necrosis, macrophagy and muscle regeneration with perivascular inflammatory infiltrates with a large component of macrophagic cells. A tendency to perifascicular atrophy was also noticed. The expression of MHC class I antigens predominated in the perifascicular zones. Raised muscle enzymes were detected in 7 patients. Conclusion: A characteristic clinic-pathological pattern, including a myasthenia gravis-like syndrome plus myositis was found in patients receiving PD-1 and PD-1 L inhibitors. A large component of macrophages resembling granulomas seems to be the pathological hallmark of the syndrome. Further information is required to understand the wide spectrum of immune-related adverse events involving the muscle during or after treatment with anti-PD-1 inhibitors, but the pathological picture seems to be characteristic. en_US
dc.language.iso eng en_US
dc.publisher Elsevier en_US
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by/2.5/ar/
dc.subject Miositis en_US
dc.subject Myositis en_US
dc.subject Muscular Diseases en_US
dc.subject Enfermedades Musculares en_US
dc.title Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern en_US
dc.type info:eu-repo/semantics/publishedVersion
dc.type info:eu-repo/semantics/article en_US
dcterms.subject Autoimmunity
dcterms.subject Autoinmunidad
dc.description.fil Fil: Antoniol, María Noelia. Fleni. Departamento de Medicina Interna. Sección de Reumatología; Argentina.
dc.description.fil Fil: Selva O’Callaghan, Albert. Hospital Vall d'Hebron. Internal Medicine Department. Systemic Autoimmune Diseases Unit; España.
dc.description.fil Fil: Grau, Josep María. Hospital Clínic de Barcelona. Internal Medicine Department. Muscle Research Unit; España. Universidad de Barcelona. Center for Biomedical Research on Rare Diseases; España.
dc.description.fil Fil: Padrosa, Joan. Hospital Clínic de Barcelona. Internal Medicine Department. Muscle Research Unit; España. Universidad de Barcelona. Center for Biomedical Research on Rare Diseases; España.
dc.description.fil Fil: Milisenda, José C. Hospital Clínic de Barcelona. Internal Medicine Department. Muscle Research Unit; España. Universidad de Barcelona. Center for Biomedical Research on Rare Diseases; España.
dc.description.fil Fil: Matas-García, Ana. Hospital Clínic de Barcelona. Internal Medicine Department. Muscle Research Unit; España. Universidad de Barcelona. Center for Biomedical Research on Rare Diseases; España.
dc.description.fil Fil: Prieto-González, Sergio. Hospital Clínic de Barcelona. Department of Autoimmune Diseases; España. Universitat de Barcelona; España.
dc.description.fil Fil: Cabrera, Carlos. Hospital Clínic de Barcelona. Medical Oncology Department; España.
dc.description.fil Fil: Reguart, Noemi. Hospital Clínic de Barcelona. Medical Oncology Department; España.
dc.description.fil Fil: Castrejón, Natalia. Hospital Clínic de Barcelona. Pathology Department; España.
dc.description.fil Fil: Solé, Manel. Hospital Clínic de Barcelona. Pathology Department; España.
dc.description.fil Fil: Ros, Javier. Hospital Universitari Vall d'Hebron. Medical Oncology Department; España.
dc.description.fil Fil: Trallero-Araguas, Ernesto. Hospital Universitari Vall d'Hebron. Rheumatology Unit; España.
dc.description.fil Fil: Vila-Pijoan, Gemma. Hospital Universitari Vall d'Hebron. Immunology Department; España.
dc.relation.ispartofVOLUME 19
dc.relation.ispartofNUMBER 2
dc.relation.ispartofPAGINATION 102455
dc.relation.ispartofCOUNTRY Estados Unidos
dc.relation.ispartofCITY Nueva York
dc.relation.ispartofTITLE Autoimmunity reviews
dc.relation.ispartofISSN 1873-0183
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Dateien zu dieser Ressource

Das Dokument erscheint in:

Zur Kurzanzeige

info:eu-repo/semantics/openAccess Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: info:eu-repo/semantics/openAccess

DSpace Suche


Stöbern

Mein Benutzerkonto

Statistik